Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Jon C. Ogg | Sep 24, 2020 at 11:32 AM EDT

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

Some small-cap companies will screen as having deep value, but many value stocks are deemed to be "cheap" because they…

Chris Lange | Sep 23, 2020 at 12:52 PM EDT

GoodRx Enters the Market With a Bang

Telemedicine platform provider GoodRx entered the market with a bang on Wednesday.

Chris Lange | Sep 23, 2020 at 11:56 AM EDT

Is It Over for AC Immune After This Alzheimer’s Study?

AC Immune stock was absolutely crushed on Wednesday after the firm announced disappointing results from its midstage Alzheimer’s disease study.

Chris Lange | Sep 23, 2020 at 11:09 AM EDT

MediciNova Takes a Big Step in the Fight Against COVID-19

MediciNova has announced progress in its COVID-19 vaccine prototype, which stands out from the rest as it is administered intranasally.

Douglas A. McIntyre | Sep 23, 2020 at 6:24 AM EDT

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Lack of social distancing and mask-wearing in some parts of the country, coupled with cold weather that will drive people…

Jon C. Ogg | Sep 22, 2020 at 11:16 AM EDT

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

It is fair to ask if Illumina's stock has fallen too much on the acquisition announcement. After all, Grail could…

Chris Lange | Sep 21, 2020 at 11:44 AM EDT

What This Acquisition Adds to Illumina

Illumina shares dipped early Monday after the company announced that it would be making a critical acquisition of Grail.

Jon C. Ogg | Sep 21, 2020 at 10:31 AM EDT

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

Truist Securities initiated CorMedix with a Buy rating and a $20 price target. The stock closed below $5 a share…

Chris Lange | Sep 21, 2020 at 9:43 AM EDT

PMV Pharmaceuticals Closes in on IPO

Precision oncology company PMV Pharmaceuticals intends to price more than 7.35 million shares for an initial public offering valued up…

Douglas A. McIntyre | Sep 20, 2020 at 7:07 AM EDT

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

The Centers for Disease Control (CDC) has changed its rule about who should get COVID-19 testing. Most recently, it backtracked…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

Douglas A. McIntyre | Sep 19, 2020 at 9:00 AM EDT

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

According to the Centers for Disease Control and Prevention, Mississippi had the highest level of obesity last year. Most of…

Jon C. Ogg | Sep 19, 2020 at 6:15 AM EDT

Why Gilead’s Big Acquisition Adds Even More Risk

Gilead Sciences would not be the first company to pile on more debt to make an acquisition, but it is…

Chris Lange | Sep 18, 2020 at 10:31 AM EDT

Why This Cancer Detection IPO Could Be a Big Hit

Cancer-detection-focused health care company Grail has filed with the SEC, regarding its initial public offering.

Chris Lange | Sep 17, 2020 at 12:37 PM EDT

Rigel Pharma Moves Forward With Midstage COVID-19 Study

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) has announced that it will push forward with a midstage trial in the treatment of…

1 … 40 41 42 43 44 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

GoodRx Enters the Market With a Bang

Is It Over for AC Immune After This Alzheimer’s Study?

MediciNova Takes a Big Step in the Fight Against COVID-19

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

What This Acquisition Adds to Illumina

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

PMV Pharmaceuticals Closes in on IPO

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

This Week in Coronavirus News

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

Why Gilead’s Big Acquisition Adds Even More Risk

Why This Cancer Detection IPO Could Be a Big Hit

Rigel Pharma Moves Forward With Midstage COVID-19 Study

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Health and Healthcare Articles

All Health and Healthcare Articles

Catalyst Pharmaceuticals Looks Cheap, but Few Catalysts for Massive Upside

GoodRx Enters the Market With a Bang

Is It Over for AC Immune After This Alzheimer’s Study?

MediciNova Takes a Big Step in the Fight Against COVID-19

Wildely Followed Forecast Puts US COVID-19 Deaths at 378,000 With December Surge

Are Analysts Underestimating What Grail Brings for Illumina’s Future Growth?

What This Acquisition Adds to Illumina

Why CorMedix Could See 300% Upside From the Defencath Central Venous Catheter

PMV Pharmaceuticals Closes in on IPO

Here’s The Tricky Part Of The CDC Rules About COVID-19 Testing

This Week in Coronavirus News

Mississippi’s Obesity Rate Is Over 40%, the Highest in America

Why Gilead’s Big Acquisition Adds Even More Risk

Why This Cancer Detection IPO Could Be a Big Hit

Rigel Pharma Moves Forward With Midstage COVID-19 Study

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation